nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—DDR2—Endochondral Ossification—ALPL—sclerosing cholangitis	0.0489	0.0819	CbGpPWpGaD
Regorafenib—PDGFRA—gall bladder—sclerosing cholangitis	0.0305	0.0759	CbGeAlD
Regorafenib—KIT—gall bladder—sclerosing cholangitis	0.0244	0.0606	CbGeAlD
Regorafenib—PDGFRB—gall bladder—sclerosing cholangitis	0.0238	0.0592	CbGeAlD
Regorafenib—FRK—liver—sclerosing cholangitis	0.0225	0.0559	CbGeAlD
Regorafenib—TEK—Wnt Signaling Pathway Netpath—TCF4—sclerosing cholangitis	0.0223	0.0374	CbGpPWpGaD
Regorafenib—DDR2—liver—sclerosing cholangitis	0.0202	0.0501	CbGeAlD
Regorafenib—MAPK11—CDO in myogenesis—TCF4—sclerosing cholangitis	0.0183	0.0307	CbGpPWpGaD
Regorafenib—TEK—Angiogenesis—HIF1A—sclerosing cholangitis	0.0183	0.0307	CbGpPWpGaD
Regorafenib—EPHX2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.018	0.0301	CbGpPWpGaD
Regorafenib—FLT1—Angiogenesis—HIF1A—sclerosing cholangitis	0.0165	0.0276	CbGpPWpGaD
Regorafenib—EPHA2—pancreas—sclerosing cholangitis	0.0159	0.0396	CbGeAlD
Regorafenib—TEK—pancreas—sclerosing cholangitis	0.0155	0.0386	CbGeAlD
Regorafenib—FLT1—pancreas—sclerosing cholangitis	0.015	0.0373	CbGeAlD
Regorafenib—RAF1—pancreas—sclerosing cholangitis	0.0149	0.0371	CbGeAlD
Regorafenib—BRAF—liver—sclerosing cholangitis	0.0143	0.0354	CbGeAlD
Regorafenib—FLT1—VEGFR1 specific signals—HIF1A—sclerosing cholangitis	0.0142	0.0238	CbGpPWpGaD
Regorafenib—ABL1—CDO in myogenesis—TCF4—sclerosing cholangitis	0.0137	0.023	CbGpPWpGaD
Regorafenib—EPHX2—liver—sclerosing cholangitis	0.0136	0.0338	CbGeAlD
Regorafenib—UGT1A9—liver—sclerosing cholangitis	0.0125	0.031	CbGeAlD
Regorafenib—FLT4—liver—sclerosing cholangitis	0.0123	0.0305	CbGeAlD
Regorafenib—FGFR1—liver—sclerosing cholangitis	0.0121	0.0301	CbGeAlD
Regorafenib—NTRK1—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.0117	0.0197	CbGpPWpGaD
Regorafenib—KIT—pancreas—sclerosing cholangitis	0.0112	0.0279	CbGeAlD
Regorafenib—KDR—Angiogenesis—HIF1A—sclerosing cholangitis	0.011	0.0184	CbGpPWpGaD
Regorafenib—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.011	0.0184	CbGpPWpGaD
Regorafenib—PDGFRB—pancreas—sclerosing cholangitis	0.011	0.0273	CbGeAlD
Regorafenib—NTRK1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.0105	0.0176	CbGpPWpGaD
Regorafenib—FGFR2—liver—sclerosing cholangitis	0.0103	0.0256	CbGeAlD
Regorafenib—EPHA2—liver—sclerosing cholangitis	0.0101	0.0252	CbGeAlD
Regorafenib—TEK—liver—sclerosing cholangitis	0.00988	0.0246	CbGeAlD
Regorafenib—ABL1—pancreas—sclerosing cholangitis	0.00979	0.0243	CbGeAlD
Regorafenib—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00968	0.0162	CbGpPWpGaD
Regorafenib—FLT1—liver—sclerosing cholangitis	0.00955	0.0237	CbGeAlD
Regorafenib—RAF1—liver—sclerosing cholangitis	0.0095	0.0236	CbGeAlD
Regorafenib—PDGFRA—liver—sclerosing cholangitis	0.00895	0.0222	CbGeAlD
Regorafenib—ABL1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.0087	0.0146	CbGpPWpGaD
Regorafenib—FGFR2—Angiogenesis—HIF1A—sclerosing cholangitis	0.00868	0.0145	CbGpPWpGaD
Regorafenib—MAPK11—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00857	0.0143	CbGpPWpGaD
Regorafenib—UGT1A1—liver—sclerosing cholangitis	0.00854	0.0212	CbGeAlD
Regorafenib—NTRK1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00825	0.0138	CbGpPWpGaD
Regorafenib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0081	0.0136	CbGpPWpGaD
Regorafenib—KDR—liver—sclerosing cholangitis	0.00807	0.0201	CbGeAlD
Regorafenib—PDGFRA—Angiogenesis—HIF1A—sclerosing cholangitis	0.00807	0.0135	CbGpPWpGaD
Regorafenib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00795	0.0133	CbGpPWpGaD
Regorafenib—FGFR1—Endochondral Ossification—ALPL—sclerosing cholangitis	0.00765	0.0128	CbGpPWpGaD
Regorafenib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00757	0.0127	CbGpPWpGaD
Regorafenib—TEK—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00734	0.0123	CbGpPWpGaD
Regorafenib—BRAF—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.00722	0.0121	CbGpPWpGaD
Regorafenib—KIT—liver—sclerosing cholangitis	0.00715	0.0178	CbGeAlD
Regorafenib—PDGFRB—liver—sclerosing cholangitis	0.00699	0.0174	CbGeAlD
Regorafenib—UGT1A9—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.00691	0.0116	CbGpPWpGaD
Regorafenib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.00676	0.0113	CbGpPWpGaD
Regorafenib—NTRK1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00652	0.0109	CbGpPWpGaD
Regorafenib—KDR—Notch-mediated HES/HEY network—HIF1A—sclerosing cholangitis	0.00642	0.0107	CbGpPWpGaD
Regorafenib—ABL1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00642	0.0107	CbGpPWpGaD
Regorafenib—MAPK11—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.00636	0.0106	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00627	0.0105	CbGpPWpGaD
Regorafenib—ABL1—liver—sclerosing cholangitis	0.00623	0.0155	CbGeAlD
Regorafenib—FGFR2—Neural Crest Differentiation—TCF4—sclerosing cholangitis	0.00621	0.0104	CbGpPWpGaD
Regorafenib—RAF1—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00598	0.01	CbGpPWpGaD
Regorafenib—FGFR1—Neural Crest Differentiation—TCF4—sclerosing cholangitis	0.00579	0.00968	CbGpPWpGaD
Regorafenib—NTRK1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00575	0.00963	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00574	0.0096	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00572	0.00957	CbGpPWpGaD
Regorafenib—EPHA2—NRF2 pathway—GGT1—sclerosing cholangitis	0.00529	0.00885	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00502	0.00841	CbGpPWpGaD
Regorafenib—RAF1—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.00499	0.00836	CbGpPWpGaD
Regorafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00499	0.00835	CbGpPWpGaD
Regorafenib—ABL1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00496	0.0083	CbGpPWpGaD
Regorafenib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00466	0.00779	CbGpPWpGaD
Regorafenib—CYP2C19—liver—sclerosing cholangitis	0.00463	0.0115	CbGeAlD
Regorafenib—RET—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.0046	0.00771	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00459	0.00769	CbGpPWpGaD
Regorafenib—MAPK11—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00419	0.00701	CbGpPWpGaD
Regorafenib—CYP2C8—liver—sclerosing cholangitis	0.00404	0.01	CbGeAlD
Regorafenib—ABCG2—liver—sclerosing cholangitis	0.00393	0.00976	CbGeAlD
Regorafenib—MAPK11—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00378	0.00633	CbGpPWpGaD
Regorafenib—NTRK1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00377	0.0063	CbGpPWpGaD
Regorafenib—RAF1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00363	0.00608	CbGpPWpGaD
Regorafenib—CYP2B6—liver—sclerosing cholangitis	0.00362	0.00901	CbGeAlD
Regorafenib—CYP2C9—liver—sclerosing cholangitis	0.00359	0.00892	CbGeAlD
Regorafenib—PDGFRA—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00357	0.00598	CbGpPWpGaD
Regorafenib—UGT1A1—Phase II conjugation—GGT1—sclerosing cholangitis	0.00339	0.00566	CbGpPWpGaD
Regorafenib—UGT1A9—Phase II conjugation—GGT1—sclerosing cholangitis	0.00339	0.00566	CbGpPWpGaD
Regorafenib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00326	0.00546	CbGpPWpGaD
Regorafenib—RAF1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.0032	0.00536	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—TCF4—sclerosing cholangitis	0.00313	0.00524	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00306	0.00512	CbGpPWpGaD
Regorafenib—ABCB1—pancreas—sclerosing cholangitis	0.00304	0.00757	CbGeAlD
Regorafenib—BRAF—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00303	0.00507	CbGpPWpGaD
Regorafenib—RAF1—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00292	0.00488	CbGpPWpGaD
Regorafenib—RAF1—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00288	0.00483	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00281	0.0047	CbGpPWpGaD
Regorafenib—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0028	0.00469	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—ABCB4—sclerosing cholangitis	0.00279	0.00467	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00276	0.00462	CbGpPWpGaD
Regorafenib—CYP3A4—liver—sclerosing cholangitis	0.00274	0.0068	CbGeAlD
Regorafenib—RAF1—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00262	0.00439	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00262	0.00438	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00261	0.00437	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00257	0.0043	CbGpPWpGaD
Regorafenib—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00252	0.00421	CbGpPWpGaD
Regorafenib—CYP2C19—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0025	0.00418	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00235	0.00394	CbGpPWpGaD
Regorafenib—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00229	0.00383	CbGpPWpGaD
Regorafenib—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00228	0.00382	CbGpPWpGaD
Regorafenib—UGT1A1—NRF2 pathway—GGT1—sclerosing cholangitis	0.00226	0.00378	CbGpPWpGaD
Regorafenib—UGT1A9—NRF2 pathway—GGT1—sclerosing cholangitis	0.00226	0.00378	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—TCF4—sclerosing cholangitis	0.00221	0.0037	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00217	0.00363	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00215	0.00359	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.0021	0.00351	CbGpPWpGaD
Regorafenib—UGT1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.00198	0.00331	CbGpPWpGaD
Regorafenib—UGT1A9—Biological oxidations—GGT1—sclerosing cholangitis	0.00198	0.00331	CbGpPWpGaD
Regorafenib—ABCB1—liver—sclerosing cholangitis	0.00194	0.00481	CbGeAlD
Regorafenib—NTRK1—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00193	0.00323	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—TCF4—sclerosing cholangitis	0.0019	0.00318	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00187	0.00313	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00185	0.0031	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TCF4—sclerosing cholangitis	0.00163	0.00272	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00154	0.00258	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—NOS2—sclerosing cholangitis	0.00146	0.00244	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TCF4—sclerosing cholangitis	0.00142	0.00238	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00139	0.00232	CbGpPWpGaD
Regorafenib—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00136	0.00228	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—GOT2—sclerosing cholangitis	0.00133	0.00222	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TCF4—sclerosing cholangitis	0.0013	0.00218	CbGpPWpGaD
Regorafenib—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00124	0.00207	CbGpPWpGaD
Regorafenib—CYP2B6—Biological oxidations—GGT1—sclerosing cholangitis	0.00123	0.00206	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00115	0.00192	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—GGT1—sclerosing cholangitis	0.00114	0.00192	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—GOT1—sclerosing cholangitis	0.00114	0.00192	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	0.00104	0.00174	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00101	0.00169	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000976	0.00163	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—GGT1—sclerosing cholangitis	0.000931	0.00156	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000872	0.00146	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.000849	0.00142	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ABCB4—sclerosing cholangitis	0.000826	0.00138	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ABCB4—sclerosing cholangitis	0.000826	0.00138	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000809	0.00135	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000795	0.00133	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000764	0.00128	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00076	0.00127	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	0.000701	0.00117	CbGpPWpGaD
Regorafenib—BRAF—Disease—GOT2—sclerosing cholangitis	0.000659	0.0011	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000657	0.0011	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000655	0.0011	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000651	0.00109	CbGpPWpGaD
Regorafenib—FGFR2—Disease—GOT2—sclerosing cholangitis	0.00061	0.00102	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000604	0.00101	CbGpPWpGaD
Regorafenib—KIT—Disease—GOT2—sclerosing cholangitis	0.0006	0.001	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000593	0.000992	CbGpPWpGaD
Regorafenib—FGFR1—Disease—GOT2—sclerosing cholangitis	0.000569	0.000952	CbGpPWpGaD
Regorafenib—BRAF—Disease—GOT1—sclerosing cholangitis	0.000569	0.000951	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—GOT2—sclerosing cholangitis	0.000568	0.00095	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000563	0.000941	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—NOS2—sclerosing cholangitis	0.000562	0.000941	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000561	0.000939	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.00056	0.000937	CbGpPWpGaD
Regorafenib—FGFR2—Disease—GOT1—sclerosing cholangitis	0.000527	0.000882	CbGpPWpGaD
Regorafenib—KIT—Disease—GOT1—sclerosing cholangitis	0.000518	0.000866	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—NOS2—sclerosing cholangitis	0.000514	0.00086	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ABCB4—sclerosing cholangitis	0.000514	0.000859	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—GOT2—sclerosing cholangitis	0.000511	0.000856	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000505	0.000846	CbGpPWpGaD
Regorafenib—FGFR1—Disease—GOT1—sclerosing cholangitis	0.000491	0.000822	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—GOT1—sclerosing cholangitis	0.00049	0.00082	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000489	0.000818	CbGpPWpGaD
Regorafenib—RAF1—Disease—GOT2—sclerosing cholangitis	0.000456	0.000763	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000451	0.000754	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—GOT1—sclerosing cholangitis	0.000441	0.000739	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	0.000435	0.000728	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.0004	0.00067	CbGpPWpGaD
Regorafenib—BRAF—Disease—HIF1A—sclerosing cholangitis	0.000396	0.000662	CbGpPWpGaD
Regorafenib—RAF1—Disease—GOT1—sclerosing cholangitis	0.000393	0.000658	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GOT2—sclerosing cholangitis	0.000392	0.000656	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GOT2—sclerosing cholangitis	0.000392	0.000656	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ABCB4—sclerosing cholangitis	0.000388	0.000649	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000379	0.000634	CbGpPWpGaD
Regorafenib—FGFR2—Disease—HIF1A—sclerosing cholangitis	0.000367	0.000613	CbGpPWpGaD
Regorafenib—KIT—Disease—HIF1A—sclerosing cholangitis	0.00036	0.000602	CbGpPWpGaD
Regorafenib—BRAF—Disease—NOS2—sclerosing cholangitis	0.00036	0.000602	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000357	0.000598	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.000354	0.000592	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000344	0.000576	CbGpPWpGaD
Regorafenib—FGFR1—Disease—HIF1A—sclerosing cholangitis	0.000342	0.000572	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—HIF1A—sclerosing cholangitis	0.000341	0.00057	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GGT1—sclerosing cholangitis	0.000339	0.000567	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GOT1—sclerosing cholangitis	0.000339	0.000567	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GGT1—sclerosing cholangitis	0.000339	0.000567	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GOT1—sclerosing cholangitis	0.000339	0.000567	CbGpPWpGaD
Regorafenib—FGFR2—Disease—NOS2—sclerosing cholangitis	0.000333	0.000558	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GOT2—sclerosing cholangitis	0.000333	0.000557	CbGpPWpGaD
Regorafenib—KIT—Disease—NOS2—sclerosing cholangitis	0.000328	0.000548	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000326	0.000545	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000325	0.000544	CbGpPWpGaD
Regorafenib—FGFR1—Disease—NOS2—sclerosing cholangitis	0.000311	0.00052	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—NOS2—sclerosing cholangitis	0.00031	0.000519	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—HIF1A—sclerosing cholangitis	0.000307	0.000514	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GOT1—sclerosing cholangitis	0.000287	0.000481	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GGT1—sclerosing cholangitis	0.000287	0.000481	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00028	0.000468	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NOS2—sclerosing cholangitis	0.000279	0.000467	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000277	0.000464	CbGpPWpGaD
Regorafenib—RAF1—Disease—HIF1A—sclerosing cholangitis	0.000274	0.000458	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000257	0.00043	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000252	0.000422	CbGpPWpGaD
Regorafenib—RAF1—Disease—NOS2—sclerosing cholangitis	0.000249	0.000417	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GOT2—sclerosing cholangitis	0.000244	0.000408	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000239	0.0004	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000239	0.000399	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000233	0.000391	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000215	0.00036	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GOT1—sclerosing cholangitis	0.000211	0.000352	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GGT1—sclerosing cholangitis	0.000211	0.000352	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	0.000207	0.000346	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000192	0.000321	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GOT2—sclerosing cholangitis	0.000184	0.000309	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.00018	0.000301	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	0.000178	0.000298	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	0.000178	0.000298	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	0.000168	0.000281	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GGT1—sclerosing cholangitis	0.000159	0.000266	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GOT1—sclerosing cholangitis	0.000159	0.000266	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GOT1—sclerosing cholangitis	0.000155	0.00026	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GGT1—sclerosing cholangitis	0.000155	0.00026	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	0.000145	0.000243	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	0.000145	0.000243	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	0.000111	0.000186	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	9.57e-05	0.00016	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	9.57e-05	0.00016	CbGpPWpGaD
